Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 756294, 10 pages
http://dx.doi.org/10.1155/2015/756294
Clinical Study

Effects of Ezetimibe/Simvastatin and Rosuvastatin on Oxidative Stress in Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

1Instituto de Investigación Clínica de Occidente, 45030 Guadalajara, JAL, Mexico
2Instituto de Terapéutica Experimental y Clínica, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, 44340 Guadalajara, JAL, Mexico
3Departamento de Farmacobiología, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, 44100 Guadalajara, JAL, Mexico
4Sección de Estudios de Posgrado, Escuela Superior de Medicina, Instituto Politécnico Nacional, 11340 Ciudad de México, DF, Mexico
5Department of Medicine, University of California, San Diego, CA 92093, USA

Received 28 May 2015; Accepted 6 July 2015

Academic Editor: Silvana Hrelia

Copyright © 2015 Geannyne Villegas-Rivera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Geannyne Villegas-Rivera, Luis Miguel Román-Pintos, Ernesto Germán Cardona-Muñoz, et al., “Effects of Ezetimibe/Simvastatin and Rosuvastatin on Oxidative Stress in Diabetic Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 756294, 10 pages, 2015. https://doi.org/10.1155/2015/756294.